Is ARRJF or JNJ a better dividend investment in 2026?

ARRJF currently yields 3.38% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: ARRJF offers higher current income.

What is the dividend yield difference between ARRJF and JNJ?

ARRJF has a forward dividend yield of 3.38% ($0.10/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 0.02 percentage points.

Home › Compare › ARRJF vs JNJ

ARRJF vs JNJ: Dividend Comparison 2026

ARRJF yields 3.38% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ARRJF wins by $171.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ARRJF

● Live price

3.38%

Share price

$2.97

Annual div

$0.10

5Y div CAGR

46.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$191.7K

Annual income

$83,455.04

Full ARRJF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — ARRJF vs JNJ

📍 ARRJF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ARRJF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ARRJF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ARRJF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARRJF

Annual income on $10K today (after 15% tax)

$286.94/yr

After 10yr DRIP, annual income (after tax)

$70,936.78/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, ARRJF beats the other by $70,233.17/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARRJF + JNJ for your $10,000?

ARRJF: 50%JNJ: 50%

100% JNJ50/50100% ARRJF

Portfolio after 10yr

$105.9K

Annual income

$42,141.41/yr

Blended yield

39.80%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ARRJF

Analyst Ratings

Buy

Hold

Consensus: Hold

Altman Z

2.3

Piotroski

6/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARRJF buys

JNJ buys

No recent congressional trades found for ARRJF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricARRJFJNJ

Forward yield	3.38% ✓	3.36%
Annual dividend / share	$0.10	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	46.3% ✓	5.8%
Portfolio after 10y	$191.7K ✓	$20.0K
Annual income after 10y	$83,455.04 ✓	$827.78
Total dividends collected	$159.4K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy

Year-by-year: ARRJF vs JNJ ($10,000, DRIP)

Year	ARRJF Portfolio	ARRJF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,194	$493.87	$10,676	$355.77	+$518.00 → ARRJF
2	$12,733	$755.88	$11,407	$389.39	+$1.3K → ARRJF
3	$14,800	$1,175.64	$12,198	$426.53	+$2.6K → ARRJF
4	$17,705	$1,868.37	$13,056	$467.62	+$4.6K → ARRJF
5	$22,000	$3,055.91	$13,987	$513.12	+$8.0K → ARRJF
6	$28,732	$5,191.99	$14,998	$563.56	+$13.7K → ARRJF
7	$40,014	$9,271.24	$16,098	$619.52	+$23.9K → ARRJF
8	$60,470	$17,654.28	$17,295	$681.69	+$43.2K → ARRJF
9	$101,181	$36,478.09	$18,599	$750.82	+$82.6K → ARRJF
10	$191,718	$83,455.04	$20,022	$827.78	+$171.7K → ARRJF

ARRJF vs JNJ: Complete Analysis 2026

ARRJF — Stock

Arjo AB (publ) develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, treatment and prevention of pressure injuries and leg ulcers, prevention of deep vein thrombosis, treatment of edema, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, as well as clinical consulting, maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. The company was founded in 1957 and is headquartered in Malmö, Sweden.

Full ARRJF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this ARRJF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARRJF vs SCHD ARRJF vs JEPI ARRJF vs O ARRJF vs KO ARRJF vs MAIN ARRJF vs ABBV ARRJF vs MRK ARRJF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.